|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 237.10 EUR | -5.16% |
|
-8.63% | -0.63% |
| Jul. 09 | UK Life Sciences Hits GBP3 Billion Investment Milestone | MT |
| Jul. 03 | Berenberg Updates Price Target, Estimates for UCB on Recent Pipeline Deals | MT |
| Market Cap | 45.13B 51.6B 41.63B 38.45B 72.96B 4,921B 74.19B 497B 195B 2,424B 194B 190B 8,335B | P/E 2026 * |
25.6x | P/E 2027 * | 20.2x |
|---|---|---|---|---|---|
| Enterprise Value | 44.86B 51.29B 41.38B 38.22B 72.52B 4,892B 73.74B 494B 194B 2,410B 193B 188B 8,284B | EV / Sales 2026 * |
5.26x | EV / Sales 2027 * | 4.44x |
| Free-Float |
61.59% | Yield 2026 * |
0.62% | Yield 2027 * | 0.63% |
Last Transcript: UCB
| 1 day | -5.16% | ||
| 1 week | -8.63% | ||
| Current month | -9.50% | ||
| 1 month | -10.33% | ||
| 3 months | -13.78% | ||
| 6 months | -6.95% | ||
| Current year | -0.63% |
| 1 week | 236.8 |  | 260.4 |
| 1 month | 236.8 | | 275.5 |
| Current year | 223 | | 289.5 |
| 1 year | 168.45 | | 289.5 |
| 3 years | 65.4 | | 289.5 |
| 5 years | 65.4 | | 289.5 |
| 10 years | 54.84 | | 289.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 2014-12-31 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 59 | 2020-06-30 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 2024-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 2011-12-31 | |
| Director/Board Member | 67 | 2014-12-31 | |
| Director/Board Member | 56 | 2014-04-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Jan. 14 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% | ||
| Jan. 14 | Buy | Director | 500 | 0.0003% | ||
| Jan. 14 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.16% | -8.63% | +37.37% | +202.27% | 54.4B | |
| -0.51% | +1.57% | +18.72% | -5.52% | 67.96B | |
| -2.10% | +0.89% | -49.30% | -53.47% | 41.74B | |
| +5.28% | +39.50% | +39.50% | +39.50% | 40.63B | |
| -10.83% | -14.41% | +99.15% | -44.54% | 30.38B | |
| +0.12% | -7.85% | +47.16% | -29.27% | 29.37B | |
| -1.53% | -0.13% | +65.92% | +88.58% | 23.68B | |
| +3.88% | +2.16% | +11.78% | +201.51% | 19.15B | |
| -4.75% | +11.27% | +85.63% | +394.76% | 17.68B | |
| -1.59% | -1.63% | +61.04% | +130.75% | 17.14B | |
| Average | -1.72% | -0.42% | +41.70% | +92.46% | 34.21B | |
| Weighted average by Cap. | -1.72% | -1.27% | +33.89% | +67.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.53B 9.76B 7.87B 7.27B 13.79B 930B 14.03B 94.05B 36.93B 458B 36.63B 35.83B 1,576B | 9.63B 11.01B 8.89B 8.21B 15.57B 1,051B 15.84B 106B 41.7B 518B 41.36B 40.46B 1,779B |
| Net income | 1.75B 2B 1.62B 1.49B 2.83B 191B 2.88B 19.3B 7.58B 94.05B 7.52B 7.35B 323B | 2.27B 2.6B 2.1B 1.94B 3.68B 248B 3.74B 25.06B 9.84B 122B 9.76B 9.55B 420B |
| Net Debt | -271M -310M -250M -231M -439M -29.58B -446M -2.99B -1.17B -14.57B -1.16B -1.14B -50.1B | -2.31B -2.64B -2.13B -1.97B -3.74B -252B -3.8B -25.49B -10.01B -124B -9.93B -9.71B -427B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | €237.10 | -5.16% | 222,991 |
| 26-07-09 | €250.00 | +0.52% | 266,649 |
| 26-07-08 | €248.70 | -2.01% | 303,577 |
| 26-07-07 | €253.80 | -0.24% | 242,415 |
| 26-07-06 | €254.40 | -1.97% | 169,111 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UCB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
